| 1/2 | US=35 / Câncer Friedman AD. Molecular foundations of AML pathogenesis and physiology: aberrant transcription factors in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 27-42. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; FATORES DE TRANSCRICAO; RUNX1; C-MYB; MLL; HOXA9; WT1; EVI-1; C/EBPALFA; PU.1; RARALFA; GATA-1 |
| 2/2 | US=35 / Câncer Frankfurt O, Peterson LC, Gallagher R, Tallman MS. Translating biology into clinical application: APL: a classic tale of bench to bedside. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 193-228. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE AGUDA; PML-RARALFA; COAGULOPATIA; ACIDO RETINOICO; TRIOXIDO ARSENICO; SINDROME DO ACIDO RETINOICO |